Gene Therapies That Could Transform Diseases Get Easier FDA Path

(Bloomberg) -- New therapies that may cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by the Food and Drug Administration to keep pa...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.